Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has been navigating a complex market environment characterized by both ...

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2025 results , with sales up 9.6% year on year to $269.7 million. On the other hand, next quarter’s revenue guidance of $275 million ...

As of September 30, 2024, Omnicell’s balance sheet reflected cash and cash ... in order to provide cost estimates for patient out-of-pocket expenses; this is expected to reduce the staffing ...

Omnicell, Inc. is a pharmacy management provider working towards the goal of an autonomous pharmacy. Q3 earnings looked weak on the surface with revenue and EBITDA down, but results by business ...

Omnicell (NASDAQ:OMCL) has built a highly differentiated portfolio of products and services in the medication dispensing market that puts it, in my opinion, in a strongly advantageous position as ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell, Inc., (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced ...

For anyone who wants to understand Omnicell's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by US$5.2m due to unusual ...

Ratings for Omnicell (NASDAQ:OMCL) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of ...

Automating the future of patient care. That's Omnicell's goal for its new Innovation Lab, which is opening in Austin next week. Omnicell is a health care technology company that is seeking to make ...

XT Series Cabinets, IV Compounding Technology and Analytics Solutions Featured in Stand 49 MOUNTAIN VIEW, California, March 22, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading ...

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2025 results topping the market’s revenue expectations , with sales up 9.6% year on year to $269.7 million. On the other hand, ...